Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness
NCT ID: NCT02832739
Last Updated: 2017-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2016-11-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Proactive Health Monitoring Intervention for Dementia Caregivers
NCT03665909
A Technology-based Intervention to Support Older Adults in Living Independently
NCT05626556
CONNECARE-Assuta-Case Study 1
NCT03327233
CONNECARE-Assuta-Case Study 2
NCT03327246
Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers
NCT04286139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SENACA is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. This online support system's usability, the behaviour change techniques it builds on, modes of delivery and its effects on health-related behaviour, clinical and Quality-of-Life outcomes will be established in a larger group of end-users.
Testing the usability of SENACA and practical effectiveness of this intervention is the goal of this multi-national project USECARE (www.usecare.eu).
SENACA will be implemented in two countries (Israel and Norway ) via field test with community-dwelling older adults living with chronic conditions (i.e. diabetes, COPD, chronic heart failure) and their informal caregivers.
Key element of USECARE is a field-test including a study based upon pre-experimental design with three time point measurements and a pre-usability round. Multiple methods will be used to evaluate the usability and to observe clinical and process parameters before, during and after the implementation of the enhanced SENACA prototype.
All of the results combined will provide an insight into the end-user experience, usage pattern, usability perception and potential added value of the enhanced SENACA prototype for chronic disease management in the participating countries.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SENACA - self-management support system
Use of enhanced SENACA - ICT based self-management support system prototype by study participants at home for 75-100 days
SENACA - ICT based self-management support system
SENACA - ICT based self-management support system is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. ==\> www.senaca.ch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SENACA - ICT based self-management support system
SENACA - ICT based self-management support system is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. ==\> www.senaca.ch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Chronic Heart Failure (CHF, New York Heart Association NYHA IIIIIa);
2. Diabetes Mellitus (DM, 6\< HbA1c\<9),
3. Chronic Obstructive Pulmonary Disease (COPD, GOLD I-II)
4. Special Orthopaedic Co-Morbidity (SOCM, after elective hip or knee replacement, health status temporarily destabilized respectively challenged, increased monitoring and formal/informal care).
* having support of an informal caregiver that is aged 18 years or older
* aged 50 years and older (primary end-users)
Exclusion community-dwelling older adults (primary end-users):
* known illiteracy (reading and writing difficulties)
* lack of local language proficiency
* current major mental illness of moderate to severe level
* major acute illness or surgery in past 3 months (except elective hip / knee surgery for patients with SOCM)
* participation in another intervention study
Inclusion informal caregivers (secondary end-users):
* aged 18 years or older
* named by primary end-user as designated informal caregiver providing physical, emotional and/or social support for him or her
* written informed consent
* adequate functional, sensory and cognitive abilities to use the SENACA system
Exclusion Criteria
* no internet/computer access
* inability to handle ICT-devices due to cognitive or functional disabilities
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Centre for Integrated Care and Telemedicine (NST)
UNKNOWN
Open-Evidence c/o Universitat Oberta de Catalunya
UNKNOWN
Institute for Health and Consumer Protection c/o University of Oslo, Faculty of Medicine
UNKNOWN
European Medical Network EMN AG
UNKNOWN
Assuta Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacob Gindin
Director Geriatric Services
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Larsen, MA
Role: STUDY_CHAIR
Norwegian Centre for Integrated Care and Telemedicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuta Medical Center
Tel Aviv, , Israel
University Hospital North Norway
Tromsø, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IFI.2014.0056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.